» Articles » PMID: 23908768

Structural Analysis of Autoinhibition in the Ras-specific Exchange Factor RasGRP1

Overview
Journal Elife
Specialty Biology
Date 2013 Aug 3
PMID 23908768
Citations 51
Authors
Affiliations
Soon will be listed here.
Abstract

RasGRP1 and SOS are Ras-specific nucleotide exchange factors that have distinct roles in lymphocyte development. RasGRP1 is important in some cancers and autoimmune diseases but, in contrast to SOS, its regulatory mechanisms are poorly understood. Activating signals lead to the membrane recruitment of RasGRP1 and Ras engagement, but it is unclear how interactions between RasGRP1 and Ras are suppressed in the absence of such signals. We present a crystal structure of a fragment of RasGRP1 in which the Ras-binding site is blocked by an interdomain linker and the membrane-interaction surface of RasGRP1 is hidden within a dimerization interface that may be stabilized by the C-terminal oligomerization domain. NMR data demonstrate that calcium binding to the regulatory module generates substantial conformational changes that are incompatible with the inactive assembly. These features allow RasGRP1 to be maintained in an inactive state that is poised for activation by calcium and membrane-localization signals. DOI:http://dx.doi.org/10.7554/eLife.00813.001.

Citing Articles

Modeling Platelet P2Y/ Pathway to Integrin Activation.

Patel K, Bergmeier W, Fogelson A ArXiv. 2024; .

PMID: 39483345 PMC: 11527272.


Exploring the multifaceted role of RASGRP1 in disease: immune, neural, metabolic, and oncogenic perspectives.

Fan S, Kang B, Li S, Li W, Chen C, Chen J Cell Cycle. 2024; 23(6):722-746.

PMID: 38865342 PMC: 11229727. DOI: 10.1080/15384101.2024.2366009.


targeted by H3K27me3 regulates myoblast proliferation and differentiation in mice and pigs.

Xiao L, Qiao J, Huang Y, Tan B, Hong L, Li Z Acta Biochim Biophys Sin (Shanghai). 2024; 56(3):452-461.

PMID: 38419500 PMC: 10984873. DOI: 10.3724/abbs.2024011.


Phosphorylation of RasGRP1 by Shc3 prevents RasGRP1 degradation and contributes to Ras/c-Jun activation in hepatocellular carcinoma.

Zhang X, Liu Y, Yang R, Guo Y, Yan M, Xiao Y Mol Cell Biochem. 2023; 479(9):2307-2321.

PMID: 37646951 DOI: 10.1007/s11010-023-04839-4.


Pathogen-specific structural features of Ras1 activation complex: uncovering new antifungal drug targets.

Manso J, Carabias A, Sarkany Z, de Pereda J, Pereira P, Macedo-Ribeiro S mBio. 2023; 14(4):e0063823.

PMID: 37526476 PMC: 10470544. DOI: 10.1128/mbio.00638-23.


References
1.
Rajalingam K, Schreck R, Rapp U, Albert S . Ras oncogenes and their downstream targets. Biochim Biophys Acta. 2007; 1773(8):1177-95. DOI: 10.1016/j.bbamcr.2007.01.012. View

2.
Tartaglia M, Pennacchio L, Zhao C, Yadav K, Fodale V, Sarkozy A . Gain-of-function SOS1 mutations cause a distinctive form of Noonan syndrome. Nat Genet. 2006; 39(1):75-9. DOI: 10.1038/ng1939. View

3.
Beaulieu N, Zahedi B, Goulding R, Tazmini G, Anthony K, Omeis S . Regulation of RasGRP1 by B cell antigen receptor requires cooperativity between three domains controlling translocation to the plasma membrane. Mol Biol Cell. 2007; 18(8):3156-68. PMC: 1949348. DOI: 10.1091/mbc.e06-10-0932. View

4.
Kortum R, Sommers C, Pinski J, Alexander C, Merrill R, Li W . Deconstructing Ras signaling in the thymus. Mol Cell Biol. 2012; 32(14):2748-59. PMC: 3416180. DOI: 10.1128/MCB.00317-12. View

5.
Layer K, Lin G, Nencioni A, Hu W, Schmucker A, Antov A . Autoimmunity as the consequence of a spontaneous mutation in Rasgrp1. Immunity. 2003; 19(2):243-55. DOI: 10.1016/s1074-7613(03)00209-7. View